InvestorsHub Logo
Followers 14
Posts 2297
Boards Moderated 0
Alias Born 12/20/2012

Re: MinnieM post# 231033

Sunday, 06/17/2018 5:28:50 PM

Sunday, June 17, 2018 5:28:50 PM

Post# of 403018
Karin,
"Regarding compassionate use... the company doesn't have the funds to give it out. The fastest way to get it out to those in need is via ph4."

They have not the funds for ph4(less a deal is struck quickly). There has to be a fater way. I was in a clinical trial in the 80's/early 90's. Drug never marketed. After second life threating reaction, my PCP put me on an approved drug. Patient input is vital, and should be shared. Ibelieve drug companies involved with mytomorrows are compensated for the cost of drugs-better than nothing(will double check).

"Two-sided market places such as Uber and AirBnB have used technology to improve asset allocation through distributed supply and users have seen service levels rise dramatically and prices plummet. Could we apply the same logic to medications? That’s exactly what we’re trying to do at myTomorrows. We make treatments still in development available and, where the regulatory criteria are met, leave physicians and their patients to decide whether to start treatment based on the data. In the long term, this model could lead to lower drug costs. This is what we believe in?—?earlier access to new treatments which could help patients, at a lower cost to society."

Quote from the last paragraph of below link.

https://mytomorrows.com/en/blog-preview/can-the-price-of-drugs-be-justified-based-on-r-d-investment/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News